Amalgamated Bank’s Cidara Therapeutics CDTX Stock Holding History

Amalgamated Bank’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-616	Closed	-$136K	–	1842
2025 Q4	$136K	Buy	616 +42	+7%	+$6.79K	﹤0.01%	1651
2025 Q3	$55K	Hold	574	–	–	﹤0.01%	1815
2025 Q2	$28K	Buy	+574	New	+$13.8K	﹤0.01%	1989

Amalgamated Bank's CDTX Position: Q1 2026 in Review

Amalgamated Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 616 shares — an estimated $136K sold.

Amalgamated Bank first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $136K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Amalgamated Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 616 Cidara Therapeutics shares in Q1 2026, an estimated $136K.
Amalgamated Bank first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Amalgamated Bank's Cidara Therapeutics position peaked at $136K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.